Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck's Ebola Vaccine Will Get US FDA Decision Before March Review Deadline
Nov 01 2019
•
By
Brenda Sandburg
Merck's Ebola Vaccine Application Is Getting Speedy FDA Review
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Vaccines
More from Pink Sheet